Streetbeat News

Regulatory

DARE

Trading for DARE Bioscience, Inc. (DARE) was halted at 7:50:00 p.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:50 pm

YGMZ

Trading for YGMZ was halted at 7:50:00 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:50 pm

RELIW

Trading for RELIW was halted at 7:50:00 p.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:50 pm

NAAS

NaaS Technology Inc. has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Bill Haddad

June 28, 2024 | 8:34 pm

BAC

Bank of America announced an 8% increase in its quarterly dividend to $0.28 per share. The bank also reported having $197 billion in regulatory CET1 capital and a CET1 ratio of 11.9%, which exceeds the regulatory minimum requirement.

Portfolio Pulse from Bill Haddad

June 28, 2024 | 8:33 pm

HRB

INTU

IYF

MS

VDC

XLU

As the November election approaches, President Joe Biden and former President Donald Trump propose contrasting tax policies. Trump's plan includes maintaining the 2017 Tax Cuts and Jobs Act, while Biden aims to let tax cuts for the wealthy expire and increase taxes on high earners and corporations. Stocks and ETFs in the tax-preparation and financial sectors showed mixed reactions to these proposals.

Portfolio Pulse from Michael Juliano

June 28, 2024 | 8:28 pm

SNAL

Snail, Inc. received a deficiency letter from Nasdaq due to non-compliance with the minimum bid price rule.

Portfolio Pulse from Bill Haddad

June 28, 2024 | 8:28 pm

MOB

Mobilicom has received a notification from Nasdaq regarding its failure to meet the minimum bid price requirement. This could lead to potential delisting if the company does not regain compliance within the specified period.

Portfolio Pulse from Bill Haddad

June 28, 2024 | 8:15 pm

JZXN

Jiuzi Holdings, Inc. (NASDAQ: JZXN) announced a 1-for-13 reverse share split effective on or around July 3, 2024, to regain compliance with Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 8:09 pm

CMND

Clearmind Medicine has been granted patent approval in Hong Kong for its treatment of binge behaviors.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 8:07 pm